中文         Site Map |
 
 
 
Artesun® (60mg, 3 vials) has passed WHO Prequalification
Date: Apr.28.2013
 

With the joint efforts of Guilin Pharma staff, we ushered in the exciting news. Our competitive product, Artesun® (Artesunate for injection, 60mg, 3 vials), had passed WHO Prequalification in February, 2013, which completed the successful transformation of Artesun® from 2 vials package to 3 vials package.


Artesunate for injection has rapid onset, good effect and low toxicity. It was recommended as the preferred choice on treating severe malaria in adults and children by WHO <GUIDELINES FOR THE TREATMENT OF MALARIA>, and is the first choice of emergency treatment for malaria which has saved millions of malaria patients’ life.


As early as 2010, Artesun® (60mg, 2 vials) of Guilin Pharma passed the prequalification of WHO, which was a breakthrough for the international development of Guilin Pharma: Guilin Pharma became the first domestic pharmaceutical manufacturer whose production line of API, tablet and injection all met the international GMP standard, its tablet and injection both passed the WHO qualification, and Artesun® has entered global anti-malaria market and been listed by government purchase and National Drug Reimbursement List.


Starting with resource control, Guilin Pharma established an integrated industry chain and systematic quality control in breeding and planting of Artemisia annua plants, extraction of Artemisinin, synthesis and preparation of Artesunate, production and R&D of drug combinations, it ensured the supply and quality of API and FPP.


Moreover, we take the social responsibility of a medical company instead of being satisfied with the achievement we have made. A box of Artesun® (60mg, 2 vials) includes a vial of artesunate powder for injection and an ampoule of sodium bicarbonate injection. After dissolving the Artesunate powder into the sodium bicarbonate injection, it should be diluted with 0.9% of sodium chloride injection or 5% of dextrose injection before use. A prepared sodium chloride injection may save a life in a backward medical condition or in an emergency case. Once got the propose from our first-line salesmen, Guilin Pharma decided to add a sodium chloride injection to Artesun® (60mg, 2 vials), it is not only convenient for injection, but avoid the contamination of preparation. At the same time, we developed 30mg and 120mg for patients with different body weight, these two strengths have also been submitted to WHO and entered the final evaluation stage, we believe that the two strengths will be approved soon as Artesun® (60mg, 3 vials) has been pre-qualified at present, we expect that our products will serve the patients better at that time.

 

 

 

This site is published by Guilin Pharmaceutical (Shanghai) Corporation,        which is solely responsible for its content. All rights reserved.

© Guilin Pharmaceutical (Shanghai) Co., Ltd. 2017.